|
2024 Other Outputs Learnings from implementing a surgical training programObermair, Andreas, Gebski, Val, Hanna, George B., Coleman, Mark G., Graves, Nicholas, Tang, Amy, Garrett, Andrea, Walker, Graeme, Larwood, Kelvin and Janda, Monika (2024). Learnings from implementing a surgical training program. Brisbane, QLD, Australia: The University of Queensland. doi: 10.14264/45c137b |
|
2024 Journal Article Mismatch repair status and surgical approach in apparent early-stage endometrial cancerMorton, Rhett, Webb, Penelope M., Na, Renhua, Obermair, Andreas and Farrell, Rhonda (2024). Mismatch repair status and surgical approach in apparent early-stage endometrial cancer. International Journal of Gynecological Cancer, 34 (4) ijgc-2023-005234, 535-543. doi: 10.1136/ijgc-2023-005234 |
|
2024 Journal Article Uterine transposition for fertility preservation in pelvic cancersRibeiro, Reitan, Baiocchi, Glauco, Obermair, Andreas, Costa, Caroline Nadai and Leitao, Mario (2024). Uterine transposition for fertility preservation in pelvic cancers. International Journal of Gynecologic Cancer, 34 (3), 403-408. doi: 10.1136/ijgc-2023-004992 |
|
2024 Journal Article Update on near infrared imaging technology: indocyanine green and near infrared technology in the treatment of gynecologic cancersManning-Geist, Beryl, Obermair, Andreas, Broach, Vance A, Leitao, Mario M, Zivanovic, Oliver and Abu-Rustum, Nadeem R (2024). Update on near infrared imaging technology: indocyanine green and near infrared technology in the treatment of gynecologic cancers. International Journal of Gynecologic Cancer, 34 (3), 416-420. doi: 10.1136/ijgc-2023-004583 |
|
2024 Journal Article Use of indocyanine green for ureteric illumination and visualizationObermair, Helena M, Scasso, Santiago, Laufer, Joel and Obermair, Andreas (2024). Use of indocyanine green for ureteric illumination and visualization. International Journal of Gynecologic Cancer, 34 (4) ijgc-2023-005042, 643-644. doi: 10.1136/ijgc-2023-005042 |
|
2024 Journal Article Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocolHayes, Sandra C, Spence, Rosalind R, Janda, Monika, Eakin, Elizabeth, Shannon, Catherine, Goh, Jeffrey, Beesley, Vanessa L, Vagenas, Dimitrios, Webb, Penny, Coward, Jermaine, Gordon, Louisa G, O’Neill, Helene, Williams, Merran, Rye, Sheree, Newton, Melissa J, Baniahmadi, Sara, Nascimento, Marcelo, Nicklin, James, Garret, Andrea and Obermair, Andreas (2024). Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol. BMJ Open, 14 (1) e077158, 1-9. doi: 10.1136/bmjopen-2023-077158 |
|
2023 Journal Article Experience of practicing obstetrician gynaecologists in a surgical training program in total laparoscopic hysterectomyMagalski, Gabrielle R., Obermair, Andreas, Hanna, George B., Graves, Nicholas, Coleman, Mark G., Horsham, Caitlin, Sanjida, Saira, Vasconcelos Nogueira E Silva, Carina, Rao, Archana and Janda, Monika (2023). Experience of practicing obstetrician gynaecologists in a surgical training program in total laparoscopic hysterectomy. AJOG Global Reports, 3 (3) 100249, 1-12. doi: 10.1016/j.xagr.2023.100249 |
|
2023 Journal Article Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trialObermair, Andreas, Hanna, George B., Gebski, Val, Graves, Nicholas, Coleman, Mark G., Sanjida, Saira, Horsham, Caitlin, Rao, Archana and Janda, Monika (2023). Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trial. The Australian and New Zealand Journal of Obstetrics and Gynaecology, 64 (1), 1-7. doi: 10.1111/ajo.13740 |
|
2023 Journal Article Sentinel lymph node staging versus lymphadenectomy in high risk patients: is there sufficient evidence to change practice?Obermair, Andreas (2023). Sentinel lymph node staging versus lymphadenectomy in high risk patients: is there sufficient evidence to change practice?. International Journal of Gynecologic Cancer, 33 (7), 1021-1022. doi: 10.1136/ijgc-2023-004662 |
|
2023 Journal Article Correspondence on "ESGO/ESTRO/ESP guidelines fpr the management of patients with cervical cancer: update 2023” by Cibula<i>et al</i>Obermair, Andreas and Leitao, Mario (2023). Correspondence on "ESGO/ESTRO/ESP guidelines fpr the management of patients with cervical cancer: update 2023” by Cibulaet al. International Journal of Gynecologic Cancer, 33 (7), ijgc-2023. doi: 10.1136/ijgc-2023-004645 |
|
2023 Journal Article Efficacy of exercise interventions for women during and after gynaecological cancer treatment – a systematic scoping reviewRose, Grace Laura, Stewart, Elizabeth Mary, Clifford, Briana Kristine, Bailey, Tom George, Rush, Alexandra Jane, Abbott, Claudia Rose, Hayes, Sandra Christine, Obermair, Andreas and McCarthy, Alexandra Leigh (2023). Efficacy of exercise interventions for women during and after gynaecological cancer treatment – a systematic scoping review. Supportive Care in Cancer, 31 (6) 342, 1-13. doi: 10.1007/s00520-023-07790-8 |
|
2023 Journal Article Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trialHayes, Sandra, Obermair, Andreas, Mileshkin, Linda, Davis, Alison, Gordon, Louisa G., Eakin, Elizabeth, Janda, Monika, Beesley, Vanessa L., Barnes, Elizabeth H., Spence, Rosalind Renee, Sandler, Carolina, Jones, Tamara, Vagenas, Dimitrios, Webb, Penny, Andrews, John, Brand, Alison, Lee, Yeh Chen, Friedlander, Michael, Pumpa, Kate, O’Neille, Helene, Williams, Merran, Stockler, Martin and The ECHO Collaborative (2023). Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial. BMJ Open, 13 (4) e067925, 1-10. doi: 10.1136/bmjopen-2022-067925 |
|
2023 Journal Article The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for researchViolette, Caroline J., Agarwal, Ravi, Mandelbaum, Rachel S., González, José L., Hong, Kurt M., Roman, Lynda D., Klar, Maximilan, Wright, Jason D., Paulson, Richard J., Obermair, Andreas and Matsuo, Koji (2023). The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research. Expert Review of Anticancer Therapy, 23 (4), 1-11. doi: 10.1080/14737140.2023.2194636 |
|
2023 Journal Article Can simple hysterectomy replace radical hysterectomy as treatment of early-stage cervical cancer?Obermair, Andreas and Pareja, Rene (2023). Can simple hysterectomy replace radical hysterectomy as treatment of early-stage cervical cancer?. International Journal of Gynecologic Cancer, 33 (4), 647-647. doi: 10.1136/ijgc-2023-004372 |
|
2023 Journal Article Role of adjuvant therapy in intermediate-risk cervical cancer patients: subanalyses of the SCCAN studyCibula, David, Akilli, Huseyin, Jarkovsky, Jiri, van Lonkhuijzen, Luc, Scambia, Giovanni, Meydanli, Mehmet Mutlu, Ortiz, David Isla, Falconer, Henrik, Abu-Rustum, Nadeem R., Odetto, Diego, Klát, Jaroslav, dos Reis, Ricardo, Zapardiel, Ignacio, Di Martino, Giampaolo, Presl, Jiri, Laky, Rene, López, Aldo, Weinberger, Vit, Obermair, Andreas, Pareja, Rene, Poncová, Renata, Mom, Constantijne, Bizzarri, Nicolò, Borčinová, Martina, Aslan, Koray, Salcedo Hernandez, Rosa Angélica, Fons, Guus, Benešová, Klára, Dostálek, Lukáš and Ayhan, Ali (2023). Role of adjuvant therapy in intermediate-risk cervical cancer patients: subanalyses of the SCCAN study. Gynecologic Oncology, 170, 195-202. doi: 10.1016/j.ygyno.2023.01.014 |
|
2023 Journal Article Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) StudyMajidi, Azam, Na, Renhua, Jordan, Susan J., DeFazio, Anna, Obermair, Andreas, Friedlander, Michael, Grant, Peter and Webb, Penelope M (2023). Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study. JNCI: Journal of the National Cancer Institute, 115 (5), 570-577. doi: 10.1093/jnci/djac239 |
|
2023 Conference Publication Age is the best predictor of MLH1 promotor methylation in mismatch repair deficient endometrial carcinomaGounden, S., Obermair, A., Garrett, A., Mar Fan, H. and Cummings, M. (2023). Age is the best predictor of MLH1 promotor methylation in mismatch repair deficient endometrial carcinoma. Pathology Update 2023, Melbourne, VIC, Australia, 24-26 February 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2022.12.182 |
|
2023 Journal Article Groin surveillance by serial ultrasonography rather than sentinel node biopsy or inguinofemoral lymphadenectomy for patients with vulvar cancer: a pilot studyHacker, Neville F., Barlow, Ellen L., McNally, Glenn, Morrell, Stephen, Gebski, Val and Obermair, Andreas (2023). Groin surveillance by serial ultrasonography rather than sentinel node biopsy or inguinofemoral lymphadenectomy for patients with vulvar cancer: a pilot study. Cancers, 15 (3) 831, 1-11. doi: 10.3390/cancers15030831 |
|
2022 Conference Publication Exercise during chemotherapy for recurrent ovarian cancer (ECHO-R): A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancerSandler, Carolina, Spence, Rosalind, Obermair, Andreas, Janda, Monika, Eakin, Elizabeth, Beesley, Vanessa, Vegenas, Domitrios, Gordon, Louisa, Webb, Penelope, Williams, Merran, O'Neill, Helene and Hayes, Sandi (2022). Exercise during chemotherapy for recurrent ovarian cancer (ECHO-R): A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer. HOBOKEN: WILEY. |
|
2022 Journal Article Collaborative centralization of gynaecological cancer careMoloney, Kristen, Rao, Archana and Obermair, Andreas (2022). Collaborative centralization of gynaecological cancer care. Current Opinion in Oncology, 34 (5), 518-523. doi: 10.1097/CCO.0000000000000865 |
